Raia Drogasil S.A.

As of June 30, 2026, Raia Drogasil S.A. carries a market capitalization of 29.39B, placing it among publicly traded companies globally. Its enterprise value stands at 37.33B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Raia Drogasil S.A.'s next confirmed earnings release is scheduled for November 3, 2026.

As of June 30, 2026, Raia Drogasil S.A. has 1.75B shares outstanding.

These figures are as of June 30, 2026.

As of June 30, 2026, Raia Drogasil S.A. maintains a current ratio of 1.41, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Raia Drogasil S.A. recorded 106.24M in income tax expense.

As of the close on October 22, 2026, Raia Drogasil S.A.'s stock has gained approximately 6.56% over the past 52 weeks. The 50-day moving average sits at 19.58, while the 200-day moving average is 21.01.

As of June 30, 2026, Raia Drogasil S.A. holds 652.95M in cash and equivalents against 8.59B in total debt, resulting in a net debt position of 2.92B. Total book value stands at 7.29B, with working capital of 4.12B providing operational flexibility.

These figures cover the twelve months ended June 30, 2026.

Raia Drogasil S.A.'s most recent stock split took place on December 23, 2025 with a 50:51 split ratio.